| Predicate |
Object |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D333-68
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-5377
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D409-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-496
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4535
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-454
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D333-66
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4436
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-444
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-381
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4025
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7042
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-63
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-55 |
| filingDate |
2011-04-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate |
2021-10-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
BR-112012025390-B1 |
| titleOfInvention |
TETRAHYDROBENZOTHIOPHEN COMPOUND OR SALT THEREOF AND ITS USE IN THE TREATMENT OR PREVENTION OF HYPERPHOSPHATEMIA, AS WELL AS A PHARMACEUTICAL COMPOSITION INCLUDING SUCH COMPOUND |
| abstract |
TETRAHYDROBENZOTHIOPHENE COMPOUND. A compound is provided which has an intestinal phosphate transporter (NPT-IIb) inhibitory action and is useful as an active ingredient of an agent to treat and/or prevent hyperphosphatemia. Means for solution. The present inventors have extensively studied a compound which has an NPT-IIb inhibitory action and is useful as an active ingredient of an agent to treat and/or prevent hyperphosphataemia, and thereby found that a tetrahydrobenzothiophene compound has an NPT-inhibitory action. IIb, thereby completing the present invention. The tetrahydrobenzothiophene compound of the present invention has an NPT-IIb inhibitory action and can be used as an agent to prevent and/or treat hyperphosphatemia. Selected Figure None. |
| priorityDate |
2010-04-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |